ADIPOQ and hepatocellular carcinoma: Of note is that BMI was adjusted in the GWAS of adiponectin, suggesting the putative causal relationships between adiponectin and risks of GAC and HCC might be driven by mechanisms that were independent of obesity, and indicating multiple biological roles of adiponectin.